Molecular Subtypes and Response to Neoadjuvant Chemotherapy in TNBC: Results from Brightness Phase III Study AFT-04 (Alliance)
- Citation:
- J Clin Oncol vol 37 (15 suppl) 510
- Meeting Instance:
- ASCO 2019
- Year:
- 2019
- Type:
- Abstract
- Sub type:
- Poster Discussion
- Funding:
- AFT
- Endpoint:
- Secondary-not-in-original
- Analysis:
- Primary
- Data Sharing:
- No-Data-Sharing
- Status:
- Presented/Published
- Citation Status:
- epub
- Note:
- Methodological:
- No
- Biospecimen:
- No
- SDC:
- No
- Parents:
- None
- Children:
- 3375
- Pharmas:
- Abbvie
- Grants:
- Corr. Author:
- Authors:
- Otto Metzger Filho Daniel Stover Sarah Asad Peter Ansell Mark Watson Sibylle Loibl Charles E Geyer Joyce O'Shaughnessy Michael Untch Hope S Rugo Jens Huober Mehra Golshan William Sikov David Maag Gunter von Minckwitz Priya Rastogi Kristi McIntyre Norman Wolmark Carsten Denkert Fraser Symmans
- Networks:
- CA824, LAPS-CT018, LAPS-MA036, LAPS-MO011, LAPS-OH007, LAPS-PA015, LAPS-TX035, PA125, RI005
- Study
- AFT-04
- Multiple Studies, or Legacy Studies in Alliance Study:
- Phases:
- 3
- Keywords: